1-[3-[[(2S,6R,9S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]methyl]-1,2-dihydrotriazol-5-yl]-N-[[1-[[(1S,6R,9S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]methyl]triazol-4-yl]methyl]-N-[[1-[[(2S,6R,9S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]methyl]triazol-4-yl]methyl]methanamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氧吡喃
• 英文名称: 1-[3-[[(2S,6R,9S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]methyl]-1,2-dihydrotriazol-5-yl]-N-[[1-[[(1S,6R,9S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]methyl]triazol-4-yl]methyl]-N-[[1-[[(2S,6R,9S)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]methyl]triazol-4-yl]methyl]methanamine
• 化学式: C₄₅H₆₈N₁₀O₁₅
• 分子量: 989.1
• InChiKey: QGLXICYHAXODGL-JHDOGVSGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  70
• 可旋转键数：
  12
• 环数：
  12.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  230
• 氢给体数：
  2
• 氢受体数：
  23

文献信息

• [EN] CONJUGATES OF A GLYCOPROTEIN OR A GLYCAN WITH A TOXIC PAYLOAD<br/>[FR] CONJUGUÉS D'UNE GLYCOPROTÉINE OU D'UN GLYCANE AVEC UNE CHARGE TOXIQUE
  申请人：GLYKOS FINLAND OY

  公开号：WO2014177771A1

  公开（公告）日：2014-11-06

  The invention relates to a glycoprotein-toxic pay- load molecule conjugate, a toxic payload molecule- glycan conjugate, and a pharmaceutical composi- tion.The invention further relates to a method for preparing the glycoprotein-toxic payload mole- cule conjugate, the method for modulating growth of a cell population and a method of treating tu- mour cells.

  这项发明涉及一种糖蛋白-毒性载荷分子结合物、一种毒性载荷分子-糖基结合物和一种药物组合物。该发明还涉及一种制备糖蛋白-毒性载荷分子结合物的方法，一种调节细胞群体生长的方法以及一种治疗肿瘤细胞的方法。
• [EN] LINKER-PAYLOAD MOLECULE CONJUGATES<br/>[FR] CONJUGUÉS CONSTITUÉS DE MOLÉCULES DE CHARGE UTILE ET DE LIEURS
  申请人：GLYKOS FINLAND OY

  公开号：WO2014096551A1

  公开（公告）日：2014-06-26

  The invention relates to novel linker-payload molecule conjugates. The invention also relates to novel cell binder-linker-payload molecule conjugates, in particular antibdy conjugates of dolastatin or auristatin derivatives.
• [EN] ANTIBODY DRUG CONJUGATES BINDING TO HIGH-MANNOSE N-GLYCAN<br/>[FR] CONJUGUÉS MÉDICAMENT-ANTICORPS SE LIANT À UN N-GLYCANE À HAUTE TENEUR EN MANNOSE
  申请人：GLYKOS FINLAND OY

  公开号：WO2015197919A1

  公开（公告）日：2015-12-30

  The invention relates to a binding agent comprising a payload molecule and a first binding component comprising the complementarity determining regions of an antibody, wherein said antibody is capable of binding a high-mannose N-glycan.